Evidence of impaired microvascular dilatation in preterms with acute respiratory distress syndrome.

BACKGROUND: Evaluating microcirculatory function in severely ill neonates is a relevant, unmet clinical need. Inappropriate peripheral microvascular vasodilatation is thought to contribute to cardiovascular alterations in preterm infants with acute respiratory distress syndrome (ARDS). We directly evaluated microcirculatory function in preterms with ARDS. METHODS: Peripheral microvascular function was assessed in 50 newborns, divided in three groups: preterms with ARDS; at-term newborns with mild-moderate congenital cardiac disease (Cardio group); healthy controls. Skin microvascular perfusion was assessed using an operator-independent, laser-Doppler camera, under basal conditions and during post-ischemic hyperemia, allowing objective quantification of microcirculatory flow reserve (MFR). RESULTS: At baseline, perfusion was similar among the three groups. During post-ischemic phase, microcirculatory perfusion significantly increased in controls compared to baseline (baseline perfusion units [PU] 3.65±1.8 to 4.59±2.1 during hyperemia; p for trend=0.041), whereas in ARDS group perfusion tended to decrease. Comparing results across groups, ARDS showed lower values compared to either controls or Cardio groups (p<0.05). Controls, and to a lesser extent Cardio group, showed recruitable MFR (1.78±1.13 and 1.19±0.30 in controls and Cardio group, respectively). MFR was absent in ARDS (0.88±0.48; p<0.05), documenting impaired microcirculatory response. CONCLUSION: We demonstrate that it is possible to assess, non-invasively and quantitatively, vasodilator response of skin microcirculation to physiological stimuli in neonates. We also documented that microvascular vasodilation is impaired in preterms with ARDS.

Miniaturized Implantable Loop Recorder in Small Patients: An Effective Approach to the Evaluation of Subjects at Risk of Sudden Death.

BACKGROUND: The etiological diagnosis of syncope and/or palpitations in children is often challenging. However, when noninvasive conventional examinations are inconclusive, the subcutaneous miniaturized implantable loop recorder (ILR) is recommended. The aim of our study was to evaluate the efficacy of miniaturized cardiac implantable devices in the early diagnosis of arrhythmias in children ≤6 years. METHODS: From March 2014 to May 2015, 21 patients (median age 5 years) underwent implantation of miniaturized ILR at our Institution after a complete cardiac work up. Median follow-up was 10 months. RESULTS: One patient underwent device removal for pocket infection and one needed a pocket revision. Eleven (52%) patients did not show any symptom and/or arrhythmia. Eight patients experienced symptoms during ILR monitoring: six had no electrocardiographic abnormalities, two had significant sinus pauses. Two patients had significant arrhythmias without symptoms and in one of these a pacemaker was implanted. The overall diagnostic yield was 47%. CONCLUSIONS: Miniaturized ILR could be very useful to make a diagnosis and to decide future management strategies in small patients with undefined symptoms or severe cardiac diseases. Considering its characteristics, miniaturized ILR could start a new era in the diagnosis and follow-up of young patients with symptomatic and/or malignant arrhythmias.

Safety and efficacy of diazepam autoinjector for the management of epilepsy.

Benzodiazepines represent the first choice treatment of acute repetitive seizures, and diazepam is one of the main drugs administered to epileptic patients in the prehospital setting. Currently, Diazepam rectal gel is the only approved therapy for the outpatient management of seizures, but there is a growing need for alternative medications for terminating seizures that may be not only safe and effective but also socially acceptable. According to this, the autoinjector device appears to be a promising tool for the treatment of acute repetitive seizures. Recent studies comparing diazepam autoinjector (AI) with placebo suggest that diazepam AI could be a safe and effective option to treat acute repetitive seizures when administered by trained caregivers in outpatient settings. However, additional studies comparing diazepam AI with a standard treatment are necessary to define possible added benefits of this technique.

Epilepsy and its main psychiatric comorbidities in adults and children.

Psychiatric disorders seem to be more frequent in patients with epilepsy (PWE) than the general population. Although researchers have documented a strong association between epilepsy and psychiatric comorbidities, the nature of this relationship is poorly understood. According to this, psychiatric diseases are often underdiagnosed and undertreated in PWE with further decrease of the quality of life of patients. The aim of the review was to examine the most frequent psychiatric comorbidities in adults with epilepsy (AWE) and the main psychiatric comorbidities in children with epilepsy (CWE) in order to better understand the relationship between epilepsy and the development of psychiatric disorders.

Echocardiographic alterations in a child with cow's milk allergy: a case report.

INTRODUCTION: Cow's milk allergy is the most frequent food allergy in Europe and western countries and shows a wide spectrum of clinical features, including atopic dermatitis and gastrointestinal disease. To the best of our knowledge, this report is the first to describe Kawasaki disease-like clinical features and echocardiographic alterations which resolved after a cow's milk-free diet. CASE PRESENTATION: We report a case of a 9-month-old Caucasian girl with atopic dermatitis who developed clinical features commonly present in Kawasaki disease (erythematous skin rash, non-exudative conjunctivitis, fissured lips and neck lymph nodes), together with mild echocardiographic alterations (perivascular brightness, pericardial effusion) in the absence of fever. These features resolved within 2 weeks after the beginning of a cow's milk-free diet. CONCLUSION: Kawasaki disease has recently been considered a possible risk factor for subsequent allergic disease secondary to immune dysfunction. This case report suggests that the immune-related alterations which are commonly present in allergic patients could be similar to the antigen-related immune response in Kawasaki disease and thus could lead to similar clinical features.